← All trials
NCT05434156
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 27, 2022
- Primary completion
- Mar 31, 2023
- Completion date
- Mar 31, 2023
- First posted
- Jun 27, 2022
- Last posted
- Nov 14, 2022
- Enrollment
- 66
- Arms / groups
- 6 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Eleusis TherapeuticsLead sponsor
- MAC Clinical ResearchOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.